Torrent Pharmaceuticals
Overview
Torrent Pharmaceuticals is a leading pharmaceutical company based in India, known for its wide-ranging portfolio of generic and branded drugs. The company is committed to producing high-quality healthcare solutions in various therapeutic areas to meet global healthcare needs.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances Torrent Pharmaceuticals is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Torrent Pharmaceuticals holds 41 active (46 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- AVATROMBOPAG MALEATEActive2026-06-06
- LEVOKETOCONAZOLEActive2025-08-30
- VERICIGUATActive2024-11-22
- STIRIPENTOLActive2023-12-29
- PRUCALOPRIDE SUCCINATEActive2023-06-04
- ZOLPIDEM TARTRATE USPActive2023-02-23
- PENCICLOVIRActive2021-10-29
- ROFLUMILAST USPActive2021-03-11
- ALOGLIPTIN BENZOATEActive2020-12-11
- FEBUXOSTATActive2020-11-02
- SITAGLIPTIN PHOSPHATE MONOHYDRATE USPActive2018-01-19
- SILODOSINActive2016-11-15
- DIMETHYL FUMARATE USPActive2016-09-26
- RASAGILINE MESYLATEActive2016-06-21
- ANAGRELIDE HYDROCHLORIDE USPActive2015-07-13
Showing 15 of 46 Drug Master Files.
FDA compliance signals
11 FDA enforcement records linked to this company.
- 4832023-05-25
Investigations of discrepancies, failures
- 4832023-05-25
Computer control of master formula records
- 4832022-09-28
Investigations of discrepancies, failures
- 4832022-09-28
Cleaning / Sanitizing / Maintenance
- 4832022-09-28
Written record of complaint to include findings, follow-up
- warning_letter2019-10-08
FDA Warning Letter (drug product)
- 4832018-06-15
Periodic safety report missing ICSR
- 4832018-06-15
Late submission of an ICSR
- 4832018-06-15
Failure to develop written procedures
- recall — Class III2016-04-27
Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.
- 4832013-07-26
Test methods
Is this Torrent Pharmaceuticals? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.